Your browser doesn't support javascript.
loading
Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma.
Perumal, Deepak; Kuo, Pei-Yu; Leshchenko, Violetta V; Jiang, Zewei; Divakar, Sai Krishna Athaluri; Cho, Hearn Jay; Chari, Ajai; Brody, Joshua; Reddy, M V Ramana; Zhang, Weijia; Reddy, E Premkumar; Jagannath, Sundar; Parekh, Samir.
Afiliación
  • Perumal D; Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Kuo PY; Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Leshchenko VV; Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Jiang Z; Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Divakar SK; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Cho HJ; Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Chari A; Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Brody J; Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Reddy MV; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Zhang W; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Reddy EP; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Jagannath S; Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Parekh S; Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York. samir.parekh@mssm.edu.
Cancer Res ; 76(5): 1225-36, 2016 Mar 01.
Article en En | MEDLINE | ID: mdl-26873845
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Piridonas / Pirimidinas / Proteínas Represoras / Inhibidores de Proteínas Quinasas / Quinasa 4 Dependiente de la Ciclina / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Piridonas / Pirimidinas / Proteínas Represoras / Inhibidores de Proteínas Quinasas / Quinasa 4 Dependiente de la Ciclina / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2016 Tipo del documento: Article